Meghan FitzGerald (Senior Advisor to L1 Health)

Meghan FitzGerald

Meghan FitzGerald is a global healthcare operator, strategist, investor and academic. She has worked in every domain of healthcare from front line patient care through the Fortune 500 while serving as an Adjunct Associate Professor at Columbia University.

Currently Meg serves as a Senior Advisor to L1 Health. Prior to this Meg was the managing partner and helped lead L1’s inaugural investment vehicle focused on biopharma and healthcare services allocating over ~$3B in capital to date.

Prior to this Meg spent nearly twenty years in Corporate America working for many prominent healthcare companies. She was the EVP of Strategy, M&A and Health Policy at Cardinal Health (CAH) and a member of the executive committee. Prior to that, she was the President of Cardinal Health Specialty Solutions, one of the fastest growing businesses where her team took an underperforming division from $700m USD to over $8bn in four years. Before joining Cardinal, Meg was the SVP of New Markets and Business Development at Medco Health Solutions (MHS). She previously held positions in strategy and marketing at top companies including Pfizer, Merck and Sanofi-Synthelabo.

She is a member of the board of directors at Tenet Healthcare (THC) a leading Fortune 500 healthcare services company, Seniorlink a service platform supporting caregivers in the home and K2HealthVentures a life science investment fund where she is Chair and a Founding Partner. Meg just completed her third private equity deal with the acquisition of Destination Pet, a global pet care company where she is also Chair. In addition, she volunteers at her local hospital and for TrekMedics, a global non-profit dedicated to bringing emergency care from Haiti to Tanzania.

Meg obtained a Doctor of Public Health (DrPH) at New York Medical College, focusing on health policy and the social determinants of health. She earned a Master of Public Health from Columbia University and a Bachelor of Nursing from Fairfield University. Currently, Meg teaches strategy and “The Business of Healthcare” at Columbia University in New York. Her new book “Ascending Davos: A career journey from the emergency room to the board room” was launched in January 2020.

Our Team

An experienced team

Stefan C. Linn

Stefan C. Linn

Managing Partner & CEO L1 Health

Ivan Zhivago

Ivan Zhivago

Partner

Andrea Pelliccia

Andrea Pelliccia

Vice President

Franz Humer

Franz Humer

Former CEO and Chairman Roche Holding Ltd

Rolf Classon

Rolf Classon

Former CEO and President of Bayer Healthcare

Meghan FitzGerald

Meghan FitzGerald

Senior Advisor to L1 Health